Prof Kamal Malakar, an internationally-acclaimed oncologist has said cancer incidence is on the increase globally and the cost of its treatment has gone up exponentially in last 20 to 25 years Vis a Vis the linear increase of the incidence.
Speaking at the Second Indo Oncology Summit here on Saturday, Dr Malakar said, “This is multi-factorial. With ever-increasing cost of growth of complex technology and machinery, diagnostic tests, ever-increasing cost of drugs, prolongation of therapeutic regimens, prolongation of complex side effects and their management, highly-skilled and costly personnel, etc., in the beginning of 21st century, only 25 per cent of patients diagnosed with cancer worldwide can afford to receive currently-practised standard treatment.”
He informed that with progress of technology, complex treatment regimen, older but somewhat effective regimens are discarded.
“It is recommended that we look back on to what we left behind and learn their strengths and weaknesses. Because they are not in the front line in the therapeutic armamentarium, they cost pennies,” said he.
An integrated system has been developed which would deliver equally effective relief and control at fraction of the cost of currently-practised treatments for cancer, pointed out he.
By amassing the strength of all "out of favour" agents, it is possible to develop a system which can easily outbid the cutting edge science, Dr Malakar said.
For example, using preoperative shorter and smarter chemotherapy with lower dosage, multiple combinations of adjutant therapy, concurrent chemo-radiation, all supported by universal "oncotherapy and immuno-augmenter" HYPERTHERMIA, may result in equal if not higher therapeutic benefit, compared to practiced cutting edge expensive Cancer measures, advised he.
Dr Malakar has authored several scientific books and his “The Plasma” is a bestseller in the USA.